Furthermore, differential expression analysis of the five genes in GEPIA validated that three genes (G6PC3, IGFBP2, and TIMP4) were significantly up-regulated and two genes (PTPRN and RGS14) were significantly down-regulated in GBM. This evidence concerns the gene G6PC3 and glioblastoma.